Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.
Web www.patentalert.com
< Antibodies that immunospecifically bind to B lymphocyte stimulator protein
> Treatment of neurodegenerative disease through intracranial delivery of siRNA
> Method for stimulating the immune, inflammatory or neuroprotective response
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT